Anabolic Androgenic Steroids Induced Iatrogenic Cushing Syndrome in a Patient with Relapse of Antitubercular Drugs Induced Hepatitis
1★, 1★ Corresponding author
- 1Department of Pharmacy Practice, KLE College of Pharmacy, KLE Academy of Higher Education and Research, Belagavi, Karnataka, INDIA.
CORRESPONDENCE
Bandaru Yeswanth Raja
Department of Pharmacy Practice, KLE College of Pharmacy, KLE Academy of Higher Education and Research, Belagavi, Karnataka, INDIA.
Received: 08-02-2023; Revised: 27-02-2023; Accepted: 06-04-2023.
Volume 15, Issue 3 · pp. 581-584 · 2023 · DOI: 10.5530/jyp.2023.15.81
ABSTRACT
Anabolic androgenic steroids are a type of synthetic testosterone which are most likely used by athletes, body builders and physicians to increase male sex hormones in those who have not yet reached puberty. We present the case of 32-years-old male patient who was admitted in respiratory ward with complaints of breathlessness and weakness. Patient had history of left hydropneumothorax secondary due to pulmonary tuberculosis, iatrogenic cushing syndrome and was misusing anabolic androgenic steroids for muscle gain for a long time. The laboratory investigations were noted that elevation of liver function tests, abnormal haematological tests, ultrasonography was revealed to be hepatomegaly with grade II fatty liver. The patient was treated with the Dexamethasone, combination of Piperacillin and Tazobactam, combination of Metadoxine, Silymarin and l-Ornithinel-Aspartate (LOLA), Clonazepam, Ketoconazole and his health condition improved enough for him to be discharged. In conclusion we recommend the health care professionals to review the safety profile, examine laboratory results and counsel patients to prevent further abusage of anabolic androgenic steroids.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Raja, B. Y., & Ganachari, M. S. (2023). Anabolic Androgenic Steroids Induced Iatrogenic Cushing Syndrome in a Patient with Relapse of Antitubercular Drugs Induced Hepatitis. Journal of Young Pharmacists, 15(3), 581-584. https://doi.org/10.5530/jyp.2023.15.81
Copyright and licence
© 2023 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0